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Abstract: Several parameters mediate the selection of treatment modality in end-stage renal 
disease (ESRD). The nephrology community suggests that patient preference should be the 
prime determinant of modality choice. We aimed to test whether ego mechanisms of defense 
are associated with patients’ treatment modality preferences, independent of psychological 
distress. In 58 eligible ESRD patients who had themselves chosen their treatment modality, we 
administered the Symptom Distress Checklist-90-R and the Defense Style Questionnaire. Thirty-
seven patients (53.4%) had chosen hemodialysis and 21 (46.6%) peritoneal dialysis. Patients 
who preferred peritoneal dialysis were younger (odds ratio [OR], 0.89; 95% confidence interval 
[CI]: 0.804–0.988), had received more education (OR, 8.84; 95% CI: 1.301–60.161), and were 
twice as likely to adopt an adaptive defense style as compared to patients who preferred hemo-
dialysis (57.1% vs 27.0%, respectively; P  0.033). On the contrary, the latter were more likely 
to adopt an image-distorting defense style (35.1% vs 14.3%; P = 0.038) and passive–aggressive 
defenses (OR, 0.73: 95% CI: 0.504–1.006). These results were independent of psychological 
distress. Our findings indicate that the patient’s personality should be taken into account, if we 
are to better define which modalities are best suited to which patients. Also, physicians should 
bear in mind passive–aggressive behaviors that warrant attention and intervention in patients 
who preferred hemodialysis.
Keywords: end-stage renal disease, hemodialysis, peritoneal dialysis, ego mechanisms of 
defense, DSQ, psychopathology
Introduction
Patients with end-stage renal disease (ESRD) have an extremely limited range of treat-
ment choices, namely transplantation or dialysis, either hospital in-center hemodialysis 
or peritoneal dialysis – whether continuous ambulatory peritoneal dialysis (CAPD), 
automated peritoneal dialysis (APD) or nurse-assisted automated peritoneal dialysis 
(aAPD). Transplantation remains the preferred mode of renal-replacement therapy 
with respect to both outcome and cost effectiveness.1,2 However, in Greece, only one 
ninth of patients with ESRD are on transplantation list,3 while the supply of donor 
organs still remains quite limited relative to worldwide demand, and thus the dialysis-
dependent patient population continue to grow.4
Increasing patient numbers have resulted in pressure on dialysis centers and in a 
need to reorganize dialysis treatment, prompting a possible reorganization towards 
a greater use of “out-of-center” dialysis.5 A Danish health technology assessment Patient Preference and Adherence 2010:4 26
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suggests that the proportion of hemodialysis patients could 
be reduced to 55%,6 while English nephrologists propose 
a reduction 27%.7 However, in Greece, the percentage of 
patients in peritoneal dialysis is reported to be as low as 
13.3%,3 despite dialysis centers being overwhelmed, as 
indicated by the fact that there is only one nurse for as many 
as 5.54 patients in hemodialysis.3
Several parameters mediate the selection of treatment 
modality in ESRD. Each of the existing options has its own 
strengths and limitations and the nephrology community 
continues to redefine which modalities are best suited to 
which patients.4 Among the medical, individual, social, 
financial, or patients’ and nephrologists’ attitudinal factors 
influencing modality selection, patient preference is the most 
important determinant of modality decisions.8,9 It has been 
pointed out that if a patient has no strong indication for or 
against a certain form of therapy, patient preference should 
be the prime determinant of modality choice.4 Investigating 
these factors influencing patients’ preferences for treatment 
modality could help us to better define which modalities are 
best suited to which patients.
Individual characteristics previously demonstrated to be 
associated with the treatment selection have included the 
patient’s body consciousness, coping strategies, perceived 
barriers to adherence, and preference for active involvement 
in one’s health care delivery.10,11 Other investigators have 
found that the treatment selection appears to be independent 
of patient’s age and sex and is determined by their educational 
level,12 pre-dialysis educational programs,13,14 sense of auton-
omy and control,15 the doctor’s and family’s opinion,16 or 
specific personality traits such as a need for independence.15 
Although several psychological factors seem to play a sig-
nificant role in the selection of the treatment modality, there 
is little research-based discussion on the association between 
psychodynamic aspects of personality and treatment modality 
preference, while no study has focused on the relationship of 
ego mechanisms of defence with therapy selection.
Ego mechanisms of defense are defined as “automatic 
psychological processes that protect the individual against 
anxiety and from the awareness of internal or external dan-
gers and stressors, mediating the individual’s reactions to 
emotional conflicts and to internal or external stressors.”17 
Living with an end-stage disease such as ESRD is a severe 
psychological stressor and it is likely that the patient’s domi-
nant defense style may determine his or her psychological 
response and consequently his or her compliance with or 
adherence to treatment as well as treatment preferences. The 
response results from the activation of a cluster of defense 
mechanisms and is also associated with the patient’s capacity 
to cope with health stressors.18,19 Our previous research in 
patients with diabetes has shown that a “self-sacrificing” 
defense style underlies poor adherence to treatment regard-
less disease-related variables,20 while several maladaptive 
defenses were found to be strongly associated with impaired 
health-related quality of life in scleroderma and cancer 
patients.21,22 We have also found a significant positive correla-
tion between disease activity and defensive profiles in both 
ulcerative colitis and Crohn’s disease patients.23 Prompted 
by these findings, we aimed here to test the specific hypoth-
esis that ego mechanisms of defense are associated with 
selection of treatment modality in ESRD. Since we have 
previously found that psychological distress mediates the 
relationship of defense mechanisms with several outcome 
variables in patients with rheumatoid arthritis,24 but not in 
cancer patients,22 we also tested whether ego mechanisms 
of defense are independent correlates of treatment modality 




The study design was cross-sectional. The sample comprised 
consecutive patients with a confirmed diagnosis of ESRD 
attending for years the outpatient department at the Renal 
Clinic of the Hippocration General Hospital of Athens, 
Greece, during an 18-month period. The major inclusion 
criterion required that the patients chose their treatment 
modality (ie, hemodialysis or peritoneal dialysis), after the 
advantages and the disadvantages of each modality were 
explained in detail to the patients by their doctors. Exclu-
sion criteria were: strong indication for a certain form of 
therapy (ie, social problems that limit the ability of patients 
to manage a home dialysis method, such as severe poverty 
and poor hygienic conditions, or lack of family support in 
the elderly who have many comorbid conditions or, on the 
other hand, living a long distance away from hemodialysis 
centers, which can make in-center hemodialysis impossible), 
inability to read and write Greek, history of psychotic illness, 
history of alcohol and/or drug abuse or history of dementia. 
Out of 92 invited patients, 58 patients were eligible and all 
agreed to participate in the study and signed informed consent 
was obtained. The high participation rate may be due to a 
good doctor–patient relationship, taking into consideration 
that all patients had been followed by the same experienced 
nephrologists throughout the course of the disease. It should Patient Preference and Adherence 2010:4 27
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be also noted that dialysis treatment in Greece is publicly 
funded (ie, it is free to patients). The demographic charac-
teristics of the patients who had chosen either hemodialysis 
or peritoneal dialysis are presented in Table 1. All the proce-
dures followed were in accordance with the ethical standards 
on human experimentation (Helsinki Declaration of 1964) 
and were approved by the hospital’s ethical committee.
Measures
The data collection was via a semi-structured interview 
performed by the same interviewer, completion of certain 
clinical and demographic information by the interviewer 
and completion of self-report questionnaires by each par-
ticipant.
Psychological distress
Psychological distress was measured using the Symptom 
Distress Checklist-90-R (SCL-90-R), which is a 90-item 
multidimensional self-report symptom inventory designed 
to measure a wide range of psychopathological symptoms 
in psychiatric and medical patients,25 namely symptoms 
of somatization, obsessive–compulsiveness, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, 
paranoid ideation, and psychoticism. It also estimates the 
Global Severity Index (GSI) designed to measure overall 
psychological distress. Respondents rate items on a five-point 
scale reflecting their distress during the past seven days. 
A higher score indicates higher symptom intensity. Its utility 
in medical patients has been well documented25–27 and has 
also been standardized for the Greek population.28
Defense mechanisms
To measure the patients’ defensive profile we used the 
Defense Style Questionnaire (DSQ). This is an 88-item rating 
scale that is designed to estimate behavior indicating four 
defense styles.29 The “maladaptive action” style indicates 
the participants’ inability to deal with their impulses by tak-
ing constructive action on their own behalf. The essence of 
the “image-distorting” style is the splitting of the image of 
self and other into good and bad and into strong and weak. 
The “self-sacrificing” style reflects a need to perceive one’s 
self as being kind, helpful to others, and never angry. The 
“adaptive” style consists of the regarded mature defenses of 
humor, suppression, and sublimation.29,30 Each item is rated 
on a nine-point Likert interval scale. The validity of DSQ is 
established30 and it has been widely used with Greek medi-
cal patients.19–23,31
statistical analysis
All the statistical analyses were performed using the Statis-
tical Package for the Social Sciences (version 15.0; SPSS 
Inc., Chicago, IL, USA) for Windows. Summary statistics 
for all variables were calculated. Normality was tested by 
the Kolmogorov–Smirnov test.32 Univariate comparisons 
were conducted to assess differences in demographic and 
psychological variables between patients who preferred 
hemodialysis as compared to those who preferred peritoneal 
dialysis. Student’s t-tests and chi-square tests were calculated 
as appropriate.32 All the P-values were two-tailed.
Defense styles used by individual patients were defined 
by dividing subgroups according to the following criterion: 
if a subject’s score for each defense style was 0.5 standard 
deviations (SD) above the mean on a particular factor, we 
consider that this subject used that corresponding defense 
style, because a cut-off point of 0.5 SD has been considered 
to provide the best discrimination here.29 Chi-square tests 
were calculated to assess differences in defense styles used 
by patients who preferred hemodialysis as compared to those 
who preferred peritoneal dialysis.32
To test whether the defense styles used are associated with 
the treatment modality preferences independent of demo-
graphic variables and psychological distress, a multivariate 
logistic regression analysis was performed. The dependent 
variable was “treatment modality” (hemodialysis = 1, 
peritoneal dialysis = 2). Independent variables were: sex, 
age, education, and the statistically significant variables of 
psychological distress symptoms and defense styles based 
on the previous univariate analyses.
In order to test whether individual defences are associ-
ated with the treatment modality preferences independent 
of demographic variables and psychological distress, we 
repeated the previous multivariate logistic regression 
Table 1 Demographic characteristics of esRD patients who had 
chosen in-center hemodialysis (cHD) or peritoneal dialysis (PD)
Variables CHD PD P value
n 37 21
gender: Female (n, %) 21 (56.7%) 8 (38.1%) 0.095a
Age (years), range 25–82 45–80
Age (mean ± sD) 64.76 ± 8.00 58.11 ± 13.4 0.024b
Family status: married (n, %) 30 (85.7%) 20 (95.2%) 0.260a
Educational level (N, %) 0.049a
  Basic lower education 21 (56.75%) 6 (28.57%)
  High-school education 14 (37.83%) 12 (57.14%)
  University educated 2 (5.40%) 3 (14.3%)
Note: achi-square tests; btwo-tailed t-tests.
Abbreviation: sD, standard deviation.Patient Preference and Adherence 2010:4 28
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analysis. In this analysis, the defense styles were substituted 
by the statistically significant individual defenses, based on 
the results of the univariate analyses. The dependent vari-
able was again the “treatment modality” (hemodialysis = 1, 
peritoneal dialysis = 2).
Results
Patient characteristics
Table 1 presents the demographic characteristics of ESRD 
patients who selected hemodialysis or peritoneal dialysis. 
Thirty-seven patients (53.4%) selected hemodialysis and 
21 (46.6%) chose peritoneal dialysis. The majority of the 
patients were married (86.2%) and their age ranged from 25 to 
82 years, with a mean (±SD) of 60.6 ± 12.1 years. Patients who 
selected peritoneal dialysis were younger (P = 0.024) and had 
received more education (P = 0.049) compared to patients who 
selected hemodialysis. In view of these differences, the major 
demographic characteristics were included in the subsequent 
multivariate analyses as independent variables.
Psychological distress
As shown in Table 2, patients who selected hemodialysis 
showed a tendency to present higher scores on all SCL-
90 subscales as compared to those who selected peritoneal 
dialysis, but only the SCL-90 phobic anxiety subscale 
reached statistical significance (P = 0.022).
Defense styles and individual defenses
Defense styles used by individual patients are presented 
in Table 3. As shown in this table, patients who selected 
peritoneal dialysis were twice as likely to adopt an adaptive 
defense style as the patients who selected hemodialysis 
(57.1% vs 27.0%, respectively; P = 0.033) and the opposite 
was true with regard to the image-distorting defense style 
(14.3% vs 35.1%, respectively; P = 0.038). Regarding indi-
vidual defences used, patients who selected hemodialysis 
reported more frequent use of passive aggression (P = 0.049) 
and somatization (P = 0.043) than their counterparts who 
selected peritoneal dialysis (Table 4).
Multivariate analyses
Multiple logistic regression analysis with dependent vari-
able the treatment modality (ie, hemodialysis or peritoneal 
dialysis) and independent variables the major demographic 
characteristics (ie, age, sex, and education) and the statisti-
cally significant psychological distress variables and defense 
style used (ie, symptoms of phobic anxiety, image-distorting 
defense style and adaptive defense style) showed that age, 
Table 2 symptoms of psychological distress of esRD patients 
who had chosen in-center hemodialysis (cHD) or peritoneal 
dialysis (PD)
CHD N = 37  
(mean ± SD)
PD N = 21  
(mean ± SD)
P valuea
somatization 1.60 ± 0.92 1.39 ± 0.80 0.421
Obsessive–compulsive 1.33 ± 0.77 1.14 ± 0.57 0.364
interpersonal sensitivity 1.19 ± 0.77 0.96 ± 0.63 0.256
Depression 1.47 ± 0.76 1.23 ± 0.63 0.241
Anxiety 1.20 ± 1.07 0.84 ± 0.68 0.189
Hostility 0.87 ± 0.81 0.80 ± 0.83 0.783
Phobic anxiety 1.00 ± 1.01 0.54 ± 0.40 0.022
Paranoid ideation 1.25 ± 0.95 1.01 ± 0.40 0.305
Psychoticism 0.65 ± 0.51 0.61 ± 0.40 0.773
Global Symptom Index 1.23 ± 0.74 1.00 ± 0.52  0.201
Note: aTwo-tailed t-tests; a higher score indicates higher symptom intensity.
Table 3 Defense styles used by individual patients who had chosen 
in-centre hemodialysis (cHD) or peritoneal dialysis (PD)
CHD N = 37 PD N = 21
Maladaptive action 11 (29.7%) 7 (33.3%)
image-distorting 13 (35.1%) 3 (14.3%)a
Self-sacrificing 13 (35.1%) 4 (19.0%)
Adaptive 10 (27.0%) 12 (57.1%)b
Notes: aχ2 = 4.29, df = 1, P = 0.038; bχ2 = 4.52, df = 1, P = 0.033. Because some patients 
reported testing multiple defense styles, the sum of percentages in any column may 
exceed 100%.
Table 4 ego mechanisms of defense of esRD patients who had 
chosen in-center hemodialysis (cHD) or peritoneal dialysis (PD)
CHD N = 37  
(mean ± SD)
PD N = 21  
(mean ± SD)
P valuea
neurotic denial 4.32 ± 2.70 4.37 ± 1.86 0.929
Projection 3.44 ± 2.26 2.87 ± 1.44 0.268
Passive–aggressive 4.75 ± 3.47 2.90 ± 3.02 0.049
Acting out 4.77 ± 2.84 5.30 ± 1.98 0.436
splitting 4.96 ± 3.02 4.31 ± 3.03 0.465
Projective identification 1.68 ± 2.00 1.25 ± 0.91 0.290
Omnipotence 4.42 ± 2.24 3.97 ± 2.23 0.482
Undoing 5.15 ± 3.36 6.15 ± 3.51 0.324
Affiliation 4.74 ± 3.24 6.63 ± 3.16 0.345
somatization 6.91 ± 2.86 4.95 ± 3.51 0.043
Hypochondriasis 4.38 ± 2.70 4.49 ± 2.67 0.879
Note: aTwo-tailed t-tests; a higher score indicates a more intense use of the specific 
defense.Patient Preference and Adherence 2010:4 29
Defenses in end-stage renal disease Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
education, and adaptive defense style were the variables 
most closely and independently associated with the treat-
ment modality selection (Table 5). Patients who used an 
adaptive defense style were eight times as likely to select 
peritoneal dialysis as the patients who did not use this defense 
style (odds ratio [OR], 8.99; 95% confidence interval [CI]: 
2.174–86.748; P = 0.011). Along the same lines, patients 
who had received more education were eight times as likely 
to select peritoneal dialysis as the patients who had received 
less education (OR, 8.84; 95% CI: 1.301–60.161; P = 0.026), 
whereas the higher the age of the patients the lower the pos-
sibility for peritoneal dialysis selection (OR, 0.89; 95% CI: 
0.804–0.988; P = 0.029).
In order to better clarify the individual defenses that are 
possibly involved in the selection of the treatment modality, 
we repeated the previous analysis using as independent vari-
ables the significantly correlated with the treatment modality 
selection individual defenses (ie, passive–aggressive behavior 
and somatization), instead of the defense styles. As shown in 
Table 6, apart from the contribution of the major demographic 
variables (which is similar to the previous analysis), passive-
aggressive behavior was the defense mechanism most closely 
and independently associated with the treatment modality 
selection: patients who adopted a passive-aggressive defense 
mechanism were less likely to select peritoneal dialysis com-
pared to patients who did not use this defense mechanism 
(OR, 0.73; 95% CI: 0.504–1.006; P = 0.043).
Discussion
The results of the present study showed that ego mechanisms 
of defense are associated with patients’ preference of treat-
ment modality in ESRD, which confirms our main hypoth-
esis. As our results showed, patients who selected peritoneal 
dialysis were younger, had received more education, had 
less phobic anxiety symptoms, and were twice as likely to 
adopt an adaptive defense style compared with patients who 
selected hemodialysis. In addition, ESRD patients who used 
an adaptive defense style were eight times as likely to select 
peritoneal dialysis as the patients who did not use this style. 
On the contrary, patients who selected hemodialysis were 
more than twice as likely to adopt an image-distorting defense 
style, while patients who use a passive–aggressive defense 
were much more likely to select hemodialysis as the patients 
who were not passive-aggressive. Interestingly, these results 
were independent of psychological distress, which confirms 
our second hypothesis.
Although increasing patient numbers have resulted in 
pressure on dialysis centers prompting a greater use of “out-
of-center” dialysis,5 a decline in the percentage of patients with 
ESRD being treated with peritoneal dialysis has been recently 
observed,15,33,34 while the percentage of Greek ESRD patients 
being in peritoneal dialysis has been reported as low as 13.3%.3 
Given these low and declining rates of patients being in perito-
neal dialysis, there has been increasing interest in developing 
an understanding of what factors are important in influencing 
patients’ decisions concerning dialysis modality.15,34,35
Table 5 Psychological distress variables and defense styles most 
closely associated with the choice of peritoneal dialysis by esRD 
patients (n = 58)
Odds ratio (95% CI) P value
Demographics
  gender (1 = male) 3.981 (0.514–30.817) 0.186
  Age 0.891 (0.804–0.988) 0.029
  educational level 8.847 (1.301–60.161) 0.026
Psychological distress
  Phobic anxiety symptoms 3.489 (0.617–19.746) 0.158
Defense styles
  image-distorting 0.409 (0.040–4.143) 0.449
  Adaptive style 8.994 (2.174–86.748) 0.011
Notes: Multivariate Logistic regression analysis with dependent variable the treat-
ment modality (hemodialysis vs peritoneal dialysis) and independent variables the 
major demographic variables and the statistically significant variables of psychological 
distress symptoms and defense styles derived from the previous univariate analyses. 
The predictive values were calculated based on the probability of being in peritoneal 
dialysis and the cut-off value between hemodialysis and peritoneal dialysis was 0.500. 
Multivariate regression equation correctly classified 85.1% of the cases, with a Cox 
and snell r2 = 0.440.
Table 6 Psychological distress variables and ego mechanisms of 
defense most closely associated with the choice of peritoneal 
dialysis by esRD patients (n = 58)
Odds ratio (95% CI) P value
Demographics
  gender (1 = male) 1.882 (0.284–12.496) 0.513
  Age 0.928 (0.850–1.013) 0.097
  educational level 6.286 (1.217–32.464) 0.028
Psychological distress
  Phobic anxiety symptoms 3.573 (0.713–17.892) 0.121
Ego mechanisms of defense
  Passive–aggressive 0.731 (0.504–1.006) 0.043
  somatization 1.065 (0.773–1.466) 0.700
Notes: Multivariate logistic regression analysis with dependent variable the treatment 
modality (hemodialysis cs peritoneal dialysis) and independent variables the major 
demographic variables and the statistically significant variables of psychological distress 
symptoms and individual defense mechanisms based on the results of the previous 
univariate analyses. The predictive values were calculated based on the probability of 
being in peritoneal dialysis and the cut-off value between hemodialysis and peritoneal 
dialysis was 0.500. Multivariate regression equation correctly classified 76.1% of the 
cases, with a cox and snell r2 = 0.355.Patient Preference and Adherence 2010:4 30
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In our study, 46.6% of ESRD patients had chosen 
peritoneal dialysis, after the advantages and the disadvantages 
of each modality were fully explained to the patients by their 
doctors. This high proportion of patients who selected peri-
toneal dialysis is in agreement with the results of previous 
studies, that found if patients with advanced renal failure 
were offered a free choice of dialysis modality, 45% of 
those who could receive both hemodialysis and peritoneal 
dialysis would choose peritoneal dialysis.36 In addition, it 
has been also reported that if patients are actively involved 
in the decision concerning treatment modality, there is a 
substantially greater likelihood of the selection of peritoneal 
dialysis.33,35,37 Thus, our findings add further evidence for 
the significant role that patient preference might play in the 
selection of peritoneal dialysis as the preferred treatment 
modality in ESRD.
Among the demographic variables studied, age and 
educational level were the variables that differentiate our 
patients who had chosen peritoneal dialysis from those who 
had chosen hemodialysis. Consistent with the findings from 
other studies, patients who had chosen peritoneal dialysis 
were younger14,33,38–40 and had received more education12 than 
the patients who had chosen hemodialysis, although some 
studies found no relationship of age with treatment modality 
selection.12 It has been suggested15 that while physicians do 
not consider age per se to be a contraindication for home 
dialysis therapies,4,41–43 older age is associated with many 
medical and social comorbidities that make home dialysis 
difficult or impossible.4
The main finding of the present study was that specific 
personality traits, namely ego mechanisms of defense and 
defense style used, were associated with patients’ preference 
of treatment modality, independent of psychological distress. 
To the best of our knowledge, this is the first study reporting 
an association of ESRD patients’ defense style with their 
therapy preferences.
In general, in our study, patients who selected peritoneal 
dialysis used a more adaptive defense style, independent of 
age, sex, education, or psychological distress. The defenses 
that constitute the adaptive defense style–humor, suppres-
sion, and sublimation–are associated with good coping. 
Suppression allows an anxiety-provoking conflict to be put 
out of awareness until the individual is ready to deal with 
the issue. Humor reflects a capacity to accept a conflictual 
situation while taking the edge off its painful aspects and 
sublimation uses the anxiety-provoking impulse in the ser-
vice of creative response.29 Thus, adaptive style is associated 
with a constructive type of mastery of the conflict or distress. 
This is important here, since patients on peritoneal dialysis 
face several risks which may well produce several forms of 
anxiety and distress. Peritoneal dialysis has been associated 
with risk of peritonitis44,45 and infection,46 which have been 
associated with the patients’ psychosocial profile and psychi-
atric history.46 The patients’ capacity to deal with the conflict 
and distress could define their capacity to adequately com-
ply with the treatment requirements (eg, strict compliance, 
good health rules, and avoidance of insert infections). Thus, 
clinicians should pay attention to the patients’ resources to 
cope with illness and, in patients who are candidates for 
peritoneal dialysis selection, the use of the DSQ could help 
clinicians to define which patients adopt an adaptive defense 
style, which in turn enhances the criteria for the most proper 
modality selection.
On the other hand, patients who had chosen hemodialysis 
showed a tendency to adopt an image-distorting defense style, 
while patients who used a passive–aggressive defense were much 
more likely to select hemodialysis. The essence of the image-
distorting defense style is that the patient “splits” the image of 
self and other into good and bad, strong and weak, so he/she 
perceives others as “all good”, omnipotent and strong or 
“all bad”, devaluated and weak. Although in situations of 
stress these defenses could be invoked for adaptation,47 ie, 
to trust in the “omnipotence” of the physician, this style is 
mostly associated with narcissistic and borderline personal-
ity disorders.48 Often, the same individual (the physician) 
will be alternately idealized and devalued by these patients. 
Attention, understanding and, in selected cases, intervention 
in the patients’ inner psychological structure could help the 
management of this immature coping, could facilitate the 
patient to better adjust to the treatment modality selected and 
improve the patient’s compliance with treatment.
Of particular importance, to our opinion, is our finding 
that patients who use passive–aggressive defense mechanism 
habitually were much more likely to select hemodialysis. 
Passive–aggressive behavior is a defense mechanism in which 
the person indirectly and unassertively expresses aggression 
toward others,17 possibly through passivity, masochism, and 
turning against themselves.18 The resulting behavior includes 
failures or procrastinations, and even silly or provocative 
behavior in order to receive attention.18 There is also a façade 
of overt compliance masking covert resistance toward others, 
while passive aggression often occurs in response to demands 
for independent action or performance by the subject or when 
someone has disappointed the subject’s wish to be taken 
care of, regardless of whether the subject has made this wish 
known.18 It is rather obvious that passive–aggressive behavior Patient Preference and Adherence 2010:4 31
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might be dangerous, especially in patients in hemodialysis 
who, as a result of their treatment’s demands, face several 
lifestyle or diet restrictions or even disappointments when 
their wish to be taken care of by their doctors and/or nurses 
is not fulfilled, whether justified or not. The therapist’s task 
here is to help passive–aggressive patients to acknowledge 
their anger.49 As Vaillant pointed out, “the clinician must 
continually point out the probable consequences of pas-
sive–aggressive behaviour as they occur, but in every inter-
action with the patients it is important to avoid humiliating 
comments about foolish, inexplicable behaviour. Nobody’s 
pride is easier to wound than a person’s who continually 
shoots himself or herself in the foot.”49
This study has some limitations, which need to be recog-
nized. First, we used a cross-sectional design and the findings 
need to be replicated in a prospective study. Moreover, the 
drawback of using only self-report measures of independent 
psychological predictors means that we cannot refute the criti-
cism that an underlying response style might have led to our 
results. In addition to this, the DSQ that we used is an attempt 
to describe an inferred intrapsychic phenomenon that may be 
out of a subject’s awareness, an attempt that is fraught with 
difficulty.29 A review of published studies, though, indicates 
strong evidence that adaptiveness of defense style as measured 
by DSQ correlates with mental health and change.50 It is also 
possible that other factors, not included in the present study, 
such as social support, may have a mediating or moderating 
effect on patients’ preference of treatment modality. Finally, 
our finding that ego mechanisms of defense are associated 
with treatment modality selection independent of psychologi-
cal distress must be interpreted with caution, since the present 
sample size prevented us from performing a full mediation 
analysis,51,52 and therefore psychological distress was included 
in the logistic multivariable models as a confounder.
The main clinical implication of this study is that, in the 
absence of absolute clinical contraindications, the patient’s 
personality should be taken into account in treatment modal-
ity selection. ESRD patients who used habitually an adaptive 
defense style preferred more frequently peritoneal dialysis, 
whereas patients who preferred hemodialysis showed 
remarkable high rates of passive–aggressive defense, and 
this should alert physicians bear in mind passive–aggressive 
behaviors that warrant attention and intervention in patients 
in hemodialysis. The DSQ could be a useful and time-effi-
cient method for nephrologists to detect crucial personality 
traits that warrant attention if they are to suggest the most 
appropriate treatment modality. Further longitudinal stud-
ies are needed to confirm our findings with regard to the 
role that ego mechanisms of defense play in the choice of 
treatment modality by ESRD patients, including also other 
important treatment modalities, such as the pre-emptive 
transplantation. This might provide key targets to define the 
potential psychological parameters that need to be addressed 
in order to offer the best suited treatment modality selection 
in ESRD patients.
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